Funder
AstraZeneca
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Massachusetts Institute of Technology
Subject
Obstetrics and Gynaecology,Oncology
Reference53 articles.
1. PD-1 blockade in tumors with mismatch-repair deficiency;Le;N. Engl. J. Med.,2015
2. . Hamanishi, J., et al., Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. Proc. Natl. Acad. Sci. U. S. A., 2007. 104(9): p. 3360–5.
3. Zhang, L., et al., Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med., 2003. 348(3): p. 203–13.
4. Sato, E., et al., Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. U. S. A., 2005. 102(51): p. 18538–43.
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献